Informed Consent: A Monthly Review
___________________________

April 2021

This digest aggregates and distills key content addressing informed consent from a broad spectrum of peer-reviewed journals and grey literature, and from various practice domains and organization types including international agencies, INGOs, governments, academic and research institutions, consortiums and collaborations, foundations, and commercial organizations. We acknowledge that this scope yields an indicative and not an exhaustive digest product.

Informed Consent: A Monthly Review is a service of the Center for Informed Consent Integrity, a program of the GE2P2 Global Foundation. The Foundation is solely responsible for its content. Comments and suggestions should be directed to:

Editor
Paige Fitzsimmons, MA
Associate Director, Center for Informed Consent Integrity
GE2P2 Global Foundation
paige.fitzsimmons@ge2p2global.org
PDF Version: GE2P2 Global_Informed Consent – A Monthly Review_April 2021

Editor’s Note:
Informed consent for neonatal trials – Practical points to consider was the latest webinar in the Center’s continuing series held on March 17^th 2021. The invited speakers were Dr. Beate Aurich of the Institut National de la Santé et de la Recherche Médicale (INSERM) in Paris, France, and Dr. Eric Vermeulen of the Dutch Patient Association for Rare and Genetic Diseases (VSOP) in Soest, The Netherlands. The presentation was followed by a rich discussion with call participants regarding areas such as parental consent, assent and reconsent, and the role of patient and parent involvement in trials and the design of the informed consent process.